Source comparison
MK-677 Peptide vs Traditional GH Secretagogues: Key Differences
The table below compares MK-677 to peptide-based growth hormone secretagogues and exogenous GH based on receptor target, administration route, half-life, and pulsatile rhythm preservation. MK-677 (ibutamoren) GHSR1a (ghrelin receptor) Oral 4–6 hours Yes. Ampli
This comparison does not assign a generated winner or score.
- The table below compares MK-677 to peptide-based growth hormone secretagogues and exogenous GH based on receptor target, administration route, half-life, and pulsatile rhythm preservation.
- MK-677 (ibutamoren)
- GHSR1a (ghrelin receptor)
- Oral
- 4–6 hours
- Yes. Amplifies existing pulses
- Best oral bioavailability; consistent IGF-1 elevation without injection
- GHRP-2
- GHSR1a + CD36
- Subcutaneous injection
- 20–30 minutes
- Requires multiple daily injections; shorter duration limits research utility
- Ipamorelin
- GHSR1a (highly selective)
- 2 hours
- Most selective peptide secretagogue; minimal appetite/prolactin effects
- CJC-1295 (DAC)
- GHRH receptor
- 6–8 days
- Partially. Extends pulse duration
- Long half-life allows weekly dosing but blunts peak amplitude
- Exogenous GH (somatropin)
- GH receptor (direct)
- 2–3 hours
- No. Suppresses endogenous production
- Bypasses physiological feedback; highest IGF-1 elevation but risks feedback suppression
- MK-677's oral bioavailability (approximately 60%) is unique among growth hormone research tools. Peptide-based secretagogues like GHRP-2 and ipamorelin are degraded in the gastric environment and must be administered subcutaneously, which limits their use in chronic studies requiring daily dosing over weeks or months. MK-677's 4–6 hour half-life allows once-daily dosing with sustained receptor occupancy, whereas short-acting peptides require dosing 2–3 times daily to maintain effect.
- The trade-off is receptor selectivity. Ipamorelin binds almost exclusively to GHSR1a with minimal off-target effects, while MK-677 also activates ghrelin's appetite-stimulating pathways in the arcuate nucleus. For metabolic studies where appetite modulation is a confounding variable, ipamorelin offers cleaner mechanistic isolation. For studies investigating the integrated metabolic response to ghrelin signalling. Energy intake, GH secretion, and substrate partitioning. MK-677's dual action is advantageous.
- Exogenous GH produces the highest absolute IGF-1 concentrations but at the cost of suppressing endogenous GH secretion. A study in the Journal of Clinical Investigation found that participants receiving daily GH injections for 12 weeks showed 70% reduction in endogenous GH pulse amplitude within four weeks, requiring a 4–6 week washout period for recovery. MK-677 produces no such suppression, making it preferable for longitudinal studies where preserving natural feedback is critical.